Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

TP0438836 MeSH Supplementary Concept Data 2025


MeSH Supplementary
TP0438836
Unique ID
C000718061
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000718061
Entry Term(s)
1-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-3-(4-(4-hydroxy-2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)phenethyl)urea
Registry Numbers
0
Heading Mapped to
*Amides
*Benzyl Compounds
*Pyrans
Frequency
0
Note
sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor
Source
Bioorg Med Chem Lett . 2018 Dec 1;28(22):3534-3539.
Date of Entry
2021/07/08
Revision Date
2021/07/22
TP0438836 Preferred
1-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-3-(4-(4-hydroxy-2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)phenethyl)urea Broader
page delivered in 0.007s